MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
...itzerland. The virus, called NV1020, is a type of herpes simplex virusmodified so that it selectively repli.... 47P Repeated intrahepatic infusion of oncolytic herpes simplex virusnv1020 prior to second-line chemotherapy for patients sufferingfrom colorectal cancer m......bronchitis), viral infections(including influenza, herpes infections), candidiasis, bacterialinfection (including urinary tract infections), upper respiratoryinfection, lymphopenia, dizziness (including vertigo), headache,neurologic sensation disorders (including paraesthesias),infection, irritation or infl......gainstviruses and unrelated diseases, specifically herpes simplex virus,viral encephalitis and malaria. CEL-1000 appears to activate innate (very early stage) and Th1type (cellular) immune responses to induce a broad-spectrumprotection against infection in animal models. The innate immunesystem is genera......t has the potential to advance medical treatmentof herpes simplex keratitis in the U.S. Herpes simplex kerat...published in the journal Archives ofOphthalmology, herpes simplex keratitis affects approximately50,000 people annually in the United States, arising as acute...ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses
...IV-1, HIV-2,human and avian influenza viruses, and herpes simplex viruses 1 and2 (HSV-1 and HSV-2). ADVENTRX plans to initiate a Phase 1/2clinical trial of ANX-201 as a component of multi-drug therapy forthe treatment of HIV during 2007. About ADVENTRX Pharmaceuticals ADVENTRX Pharmaceuticals is a biophar......gainst viruses and unrelated diseases,specifically herpes simplex virus, viral encephalitis and malaria.CEL-1000 appears to activate innate (very early stage) and Th1 type(cellular) immune responses to induce a broad- spectrum protectionagainst infection in animal models. The innate immune system isgenerall...